Eli Lilly Q1 2025 Earnings: Mounjaro, Zepbound Push Revenue to Record $12.7 Billion Amid Strong Pipeline Momentum

Eli Lilly and Company (NYSE: LLY) delivered a blockbuster first quarter for fiscal 2025, fueled by the surging success of its diabetes and obesity treatments—Mounjaro and Zepbound—and further bolstered by…

Continue ReadingEli Lilly Q1 2025 Earnings: Mounjaro, Zepbound Push Revenue to Record $12.7 Billion Amid Strong Pipeline Momentum

FII ने किया तगड़ा निवेश – ₹34,971 Cr Index Options में! DII ने किया Profit Booking

On 16th April 2025, the Indian stock market witnessed heavy FII action, especially in Index Options, where Foreign Institutional Investors (FIIs) poured in a whopping ₹34,971.62 crores. This comes on…

Continue ReadingFII ने किया तगड़ा निवेश – ₹34,971 Cr Index Options में! DII ने किया Profit Booking